A Phase 1 Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS-9411 in Healthy Male Volunteers
Latest Information Update: 09 May 2014
At a glance
- Drugs GS 9411 (Primary)
- Indications Cystic fibrosis
- Focus Adverse reactions
- Sponsors Gilead Sciences
- 09 May 2014 New trial record